"The data are consistent with some of the InnoRx selling that we’ve talked about at length on this board. JMHO, FWIW"
I disagree. For one, the STRIDE data are very good, IMHO, and for two are you suggesting InnoRx insiders had access to data back in May/June?
In any event, the insider selling for SRDX and InnoRx hasn't been dramatic.
Market Data 
Markets 
AI
